A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.eclinm.2023.102283
PubMed Identifier: 37877001
Publication URI: http://europepmc.org/abstract/MED/37877001
Type: Journal Article/Review
Volume: 65
Parent Publication: EClinicalMedicine
ISSN: 2589-5370